Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens
- PMID: 3570469
- PMCID: PMC260523
- DOI: 10.1128/iai.55.6.1375-1380.1987
Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens
Abstract
Antibody responses to two structurally different pneumococcal polysaccharides, type 3 (SIII) and type 14 (SXIV), were examined in intact and splenectomized (Sx) A/J mice to determine whether the role of the spleen in immune responses to these antigens varies with respect to the dosage, the antigenic structure, or the interval between immunization and assay. Antibody responses to SIII and SXIV, measured over a 4-week period by radioimmunoassay, differed in antigenic load requirements, kinetics, and extent of dependence upon the spleen. Intact mice given 50 or 100 ng of SIII produced peak antibody responses on day 5, which tapered off by days 14 and 21. Intact mice given SXIV required doses 100 times greater than those of SIII to stimulate high levels of antibody response; antibody responses increased on day 5 and remained elevated through day 28. In Sx mice given 50 or 100 ng of SIII, the peak antibody response on day 5 was obliterated, but extrasplenic sources produced low levels of antibody which peaked by day 14. In Sx mice given SXIV, all anti-SXIV responses were abrogated regardless of the dose or day of assay. Differences between the anti-SIII and anti-SXIV responses in dependence upon the spleen were probably due to structural differences between the two antigens and to the localization of each to different sites in the reticuloendothelial system. These results attest to the importance of the spleen in antibacterial resistance. They show that, even in the presence of extrasplenic antibody synthesis, the spleen is required for early antibody production, the timing of which is critical for the effective clearance of bacteria.
Similar articles
-
Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens.Clin Exp Immunol. 1988 Apr;72(1):151-6. Clin Exp Immunol. 1988. PMID: 3396216 Free PMC article.
-
Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.J Immunol. 1976 Jan;116(1):52-64. J Immunol. 1976. PMID: 1446
-
The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens.APMIS. 1996 Apr;104(4):307-17. doi: 10.1111/j.1699-0463.1996.tb00722.x. APMIS. 1996. PMID: 8645471
-
Immune responses to pneumococcal polysaccharide antigens: a comparison of the murine model and the response in humans.Rev Infect Dis. 1981 Mar-Apr;3(2):224-32. doi: 10.1093/clinids/3.2.224. Rev Infect Dis. 1981. PMID: 7020042 Review.
-
Protective immunity of pneumococcal glycoconjugates.Crit Rev Microbiol. 2003;29(4):333-49. doi: 10.1080/713608018. Crit Rev Microbiol. 2003. PMID: 14636043 Review.
Cited by
-
Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens.Clin Exp Immunol. 1988 Apr;72(1):151-6. Clin Exp Immunol. 1988. PMID: 3396216 Free PMC article.
-
Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.Ann Surg. 2003 Feb;237(2):281-8. doi: 10.1097/01.SLA.0000048453.61168.8F. Ann Surg. 2003. PMID: 12560788 Free PMC article.
-
Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.Ann Surg. 1999 Feb;229(2):279-85. doi: 10.1097/00000658-199902000-00017. Ann Surg. 1999. PMID: 10024111 Free PMC article. Clinical Trial.
-
Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.Ann Surg. 1992 Mar;215(3):256-60. doi: 10.1097/00000658-199203000-00010. Ann Surg. 1992. PMID: 1543398 Free PMC article.
-
SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.Infect Immun. 1992 Oct;60(10):4146-53. doi: 10.1128/iai.60.10.4146-4153.1992. Infect Immun. 1992. PMID: 1398925 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources